Stock Details
MRK is Merck & Co., Inc.'s stock. Stock exchange NYSE (Currency USD). Average price in 50 days is 88.19$. Average daily volumn in 3 months 8.16M. Market cap 223.92B



Stock symbol : MRK. Exchange : NYSE. Currency : USD
Lastest price : 88.39$. Total volume : 5.87M. Market state POST
Click reload if you want to check the lastest price on market!!!

Merck & Co., Inc. (MRK)
Last Price
88.39$
Change
0.00
Volume
5.87M

Previous Close88.39
Open88.58
Day Range88.02-88.78
Bid86.74 x 1k
Ask88.70 x 1k
Volume5.87M
Average Volume8.16M
Market Cap223.92B
Beta0.34
52 Week Range71.50-95.72
Trailing P/E13.49
Foward P/E11.88
Dividend (Yield %)3.12%
Ex-Dividend Date2022-09-14



Financial Details


According to Merck & Co., Inc.'s financial reports the company's revenue in 2021 were 48.7B an increase( +17.07%) over the years 2020 revenue that were of 41.52B. In 2021 the company's total earnings were 13.05B while total earnings in 2020 were 7.07B( +85.71%).


Loading ...



Organization

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuti... cals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Market Cap:
223.92B
Revenue:
48.7B
Total Assets:
105.69B
Total Cash:
8.1B


News about "Merck & Co., Inc."

With Merck & Co., Inc. (NYSE:MRK) It Looks Like You'll Get What You Pay For

Source from : Yahoo Finance - 3 days ago

There wouldn't be many who think Merck & Co., Inc.'s (NYSE:MRK) price-to-earnings (or "P/E") ratio of 13.1x is worth a mention when the median P/E in the United States is similar at about 14x.See details»


merck-co-inc-mrk-is-on-the-roll-with-an-average-volume-of-837m-in-the-recent-3-months-image

Merck & Co. Inc. (MRK) is on the roll with an average volume of 8.37M in the recent 3 months

Source from : investchronicle - 2 days ago

Merck & Co. Inc. (MRK) is priced at $86.12 after the most recent trading session. At the very opening of the session, the stock price was $87.25 and reached a high price of $87.62, prior to closing ...See details»


merck-co-inc-nysemrk-price-target-increased-to-11000-by-analysts-at-svb-leerink-image

Merck & Co., Inc. (NYSE:MRK) Price Target Increased to $110.00 by Analysts at SVB Leerink

Source from : Defense World - 4 days ago

Merck & Co., Inc. (NYSE:MRK โ€“ Get Rating) had its price objective lifted by SVB Leerink from $109.00 to $110.00 in a research note released on Friday morning, Stock Target Advisor reports. SVB Leerink ...See details»


heres-why-you-should-consider-acquiring-merck-mrk-shares-image

Hereโ€™s Why You Should Consider Acquiring Merck (MRK) Shares

Source from : Yahoo - 12 days ago

Chartwell Investment Partners, an asset management company, released its second quarter 2022 investor letter. A copy of the same can be downloaded here. For the second quarter, Chartwell-managed ...See details»


What This News Means for Merck

Source from : The Motley Fool - 4 days ago

this would be $200 million in additional annual revenue for Merck. That's just a 0.4% bump over the average analyst forecast of $58.7 billion in 2022 revenue for the company. But pharma ...See details»


10 Analysts Have This to Say About Merck & Co

Source from : Business Insider - 5 days ago

According to 10 analyst offering 12-month price targets in the last 3 months, Merck & Co has an average price target of $101.5 with a high of $110.00 and a low of $88.00. Below is a summary of how ...See details»


Merck (MRK) Gains But Lags Market: What You Should Know

Source from : Zacks.com on MSN - 2 days ago

Merck (MRK) closed at $87.55 in the latest trading session, marking a +1.66% move from the prior day. This change lagged the S&P 500's 2.59% gain on the day. At the same time, the Dow added 2.66%, and ...See details»


merck-to-hold-third-quarter-2022-sales-and-earnings-conference-call-october-27-image

Merck to Hold Third-Quarter 2022 Sales and Earnings Conference Call October 27

Source from : Yahoo - 6 days ago

Merck (NYSE: MRK), known as MSD outside the United States and Canada, will hold its third-quarter 2022 sales and earnings conference call with institutional investors and analysts at 8:00 a.m. ET on ...See details»


Merck's (MRK) Keytruda Gets Four New Approvals in Japan

Source from : Nasdaq - 7 days ago

Merck & Co., Inc. MRK announced that the Ministry of Health, Labor and Welfare (MHLW) in Japan has approved its blockbuster anti-PD-1 therapy, Keytruda (pembrolizumab), for four new cancer ...See details»


miracle-mile-advisors-llc-has-121-million-stock-position-in-merck-co-inc-nysemrk-image

Miracle Mile Advisors LLC Has $1.21 Million Stock Position in Merck & Co., Inc. (NYSE:MRK)

Source from : Defense World - 10 days ago

Miracle Mile Advisors LLC lowered its stake in Merck & Co., Inc. (NYSE:MRK โ€“ Get Rating) by 2.2% during the second quarter, according to the company in its most recent Form 13F filing with the SEC.See details»


pharmaceutical-company-spends-1-million-to-convert-north-baton-rouge-site-to-ear-tag-manufacturing-plant-image

Pharmaceutical company spends $1 million to convert North Baton Rouge site to ear tag manufacturing plant

Source from : The Advocate - 1 days ago

A major international pharmaceutical company has spent more than $1 million to convert a North Baton Rouge veterinary medicine manufacturing facility into a plant that makes ear tags for cattle.See details»


AL Amyloidosis Pipeline Landscape Analysis of 10+ Companies by DelveInsight | Leading Players โ€“ Sanofi, Merck & Co, and Others

Source from : MarketWatch - 1 days ago

DelveInsightโ€™s, โ€œ AL Amyloidosis Pipeline Insight, 2022,โ€ report provides comprehensive insights about 10+ companies and 10+ pipeline drugs in AL Amyloidosis pipeline landscape. AL Amyloidosis ...See details»


Merck KGaA, Darmstadt, Germany, Partners with CNote to Invest $20 Million in Under-resourced Communities

Source from : Business Insider - 1 days ago

Investment will help expand access to capital, entrepreneurship and opportunity in U.S. locations where the company has significant ...See details»


U.S. Court of Appeals for the Federal Circuit Rules in Favor of Merck in Sitagliptin Dihydrogen Phosphate Patent Lawsuit

Source from : MarketWatch - 6 days ago

Merck (NYSE: MRK), known as MSD outside of the United States and Canada, announced today that the U.S. Court of Appeals ...See details»